Cannabis Law Report

NOVEMBER 20, 2021

he Alabama State Board of Medical Examiners Thursday announced draft rules to govern how physicians can recommend medical cannabis to eligible patients. The draft rules were developed in accordance with the state’s new law on medical cannabis, which was approved earlier this year by the state Legislature and signed into law by the governor.

Patients 52

Patients DEA Dispensary Conditions 52

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. Despite the widespread adoption, the Food and Drug Administration still classifies cannabis as a Schedule One drug. Simply put, in the eyes of federal law, cannabis is illegal. Is Medical Cannabis Legal? allow the use of medical cannabis.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

TheAnswerPage

APRIL 14, 2020

Epidiolex, a CBD product derived from the cannabis plant, received FDA approval for the treatment of Lenox Gastaut syndrome and Dravet syndrome in November 2018. Since Epidiolex is no longer a controlled substance, physicians are not required to notify the DEA when prescribing the medication. Is Epidiolex a controlled substance?

DEA 52

DEA Treatment Programs Medicine 52

SpeedWeed

AUGUST 11, 2021

MAPS, The Multidisciplinary Association for Psychedelic Substances, was awarded a $12,979,050 million grant from the state of Michigan to fund a study on PTSD and cannabis on August 10. This grant enables more rigorous study, overseen by the FDA, which may lead to cannabis flower becoming prescribable medicine someday.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

CannaMD

AUGUST 8, 2020

– because today’s post is a deep dive into everything you need to know about the most popular cannabis compound around. Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol. Researchers believe cannabis contains over 100 unique chemical compounds!

CBD 99

CBD DEA Research and Development Hemp 99

The Blunt Truth

OCTOBER 3, 2019

Plus, a new bill would legalize cannabis with state-run stores. In Minnesota , lawmakers are conducting “Be Heard on Cannabis” discussions, so that citizens can share their views on legal marijuana. And Michigan is expanding the number of communities eligible for its social equity program.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers.

Legalization 99

Legalization Decriminalization Medicine Research and Development 99

Cannabis Law Report

NOVEMBER 9, 2019

That includes things like moving money out of the DEA and into overdose treatment programs, as well as really examining some of the ways that we can also decriminalize the use and study of psychedelic compounds for medicinal applications and future policies.”.

Decriminalization 45

Decriminalization DEA Policy Events 45

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. today announced a joint partnership with the intent to study the DNA sequence variation of three Clever Leaves’ cannabis cultivars as part of their Project Change Lives campaign.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

MedicalJane

JUNE 29, 2018

None of the approved drugs contain, or are derived from, the whole cannabis plant. The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. a Canada-based medical cannabis firm.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

MedicalJane

JUNE 29, 2018

At the time of this article’s publishing, thirty states and the District of Columbia have enacted legislation permitting use of medical cannabis. Do you qualify for medical cannabis? There is no universal handbook for a medical cannabis program. Can your current doctor “prescribe” cannabis?

Patients 83

Patients Legalization Conditions Treatment 83

Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. by eating or smoking cannabis) are unknown. Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Drug Enforcement Agency (“DEA”). Id ; 21 CFR 312.1-10; 10; 312.80-88; 88; 312.300 et seq.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JULY 30, 2021

On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). We strongly encourage participation in this important opportunity to shape federal cannabis policy.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

The Cannigma

MAY 1, 2023

According to the DEA, “substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.” Brain plasticity is basically the brain’s ability to adapt to stress, trauma, and injury. 9 How is ketamine commonly used?

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

CannaMD

MAY 6, 2020

Just like using medical marijuana in residential apartments , traveling with cannabis comes down to federal versus state law. Since federal law supersedes state law, this also means that taking cannabis across state lines (even if both states permit medical marijuana use) is illegal. In practice, however, it’s very ambiguous.

Hash 103

Hash Legalization Marijuana Concentrates 103

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

Canna Law Blog

JANUARY 17, 2020

other known or potential challenges by the participation of States or producers in the domestic hemp production program. other known or potential challenges by the participation of States or producers in the domestic hemp production program. 2020 is likely going to be another big year for cannabis, especially at the federal level.

Hemp 97

Hemp CBD Food Cannabinoids 97

Canna Law Blog

SEPTEMBER 28, 2019

We’ve written a lot about cannabis and the Controlled Substances Act. Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. From immigration to waste dumping. The ruling is Albuquerque Public Schools v.

Education 61

Education Oil DEA Cannabis 61

Cannabis Law Report

JUNE 15, 2021

In addition to eliminating criminal penalties for drug possession at the federal level, the bill also incentivizes state and local governments to adopt decriminalization policies by otherwise limiting their eligibility to receive funds in the Byrne and COPS grant programs. Promotes evidence-based drug education.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. They are responsible for giving you information about the treatment and proper use. Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma.

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. They are responsible for giving you information about the treatment and proper use. Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma.

Marijuana 52

Marijuana Patients Conditions Programs 52

Canna Law Blog

OCTOBER 23, 2020

With the evolution of the United States’ relationship with cannabis over recent decades, numerous parties have petitioned the U.S. Drug Enforcement Administration (“DEA”) to reschedule marijuana. But here, it basically allowed the DEA to continue its practice of effectively ignoring petitions for decades. In Sisley, et al.

DEA 69

DEA Policy History Treatment 69

Veriheal

JUNE 29, 2021

This Act permits individuals that have been diagnosed with life-threatening conditions or diseases that have exhausted all other approved treatment and therapeutic options that are also unable to participate in clinical trials the ability to access certain treatments that would otherwise be unapproved for access.

Therapy 53

Therapy DEA Patients Clinical Trials 53

CannaMD

SEPTEMBER 10, 2020

Is it safe to continue cannabis-based therapies during pregnancy? In the mid-20th century era of “reefer madness,” the mainstream view on cannabis and pregnancy was clear: expecting mothers who used marijuana were considered ‘derelict’ and in some cases criminally negligent for the endangerment of their unborn child.

Marijuana 59

Marijuana Therapy Data THC 59

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

CannaMD

NOVEMBER 15, 2020

In the United States, most cannabis research to date has focused on the potential harms of the plant, instead of its benefits. funders use their money for cannabis research. His findings are sure to alarm medical cannabis professionals and patients alike. WHY ISN’T MORE RESEARCH DONE ON CANNABIS THERAPEUTICS?

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

Cannabis Law Report

SEPTEMBER 12, 2022

Government Agencies seek funding to research cannabinoids as treatments for various conditions: [link]. Florida Ag Commissioner blasts Biden administration for arguing in lawsuit that medical cannabis patients “are too dangerous to trust” to possess firearms: [link]. Virginia 2024 adult use program may be postponed: [link].

DEA 98

DEA Dispensary Hemp Therapy 98

The Cannigma

FEBRUARY 16, 2022

Part of our conversation today centers on how we can break down barriers and find ways to build cannabis companies that are minority-owned and uplift them. one of our science reviewers at The Cannigma and a cannabis trichome expert who is getting his master’s in Plant Sciences. Elana Goldberg: Hi, I’m Elana Goldberg.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. These designations indicate that psychedelics may represent substantial improvements over existing treatments for mental health conditions.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. of the global population uses cannabis annually, making it the most commonly used drug worldwide. It should be noted that cannabis and marijuana are not interchangeable terms.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52